Michael Waldholz, Staff Reporter of The Wall Street Journal
New studies indicate that the only vaccine available for preventing hepatitis B doesn t transmit the virus associated with AIDS, or acquired immune deficiency syndrome. A widespread fear that the vaccine might carry the AIDS virus has sharply limited the vaccine s use. The information was presented by researchers d
BOSTON -- Health-care workers exposed to acquired immune deficiency syndrome, or AIDS, face low risk of contracting the disease, according to a study made public yesterday at Massachusetts General Hospital. The announcement follows reports that a laboratory technician in Boston contracted AIDS, possibly from a needle p
Marilyn Chase, Staff Reporter of The Wall Street Journal
SAN FRANCISCO -- Researchers at the University of California reported encouraging headway in treating a type of pneumonia that is the most common fatal side effect of acquired immune deficiency syndrome, or AIDS. AIDS is a viral disease that ravages the body s immune system, making way for so-called opportunistic infec
Marilyn Chase, Staff Reporter of The Wall Street Journal
Scientists at the National Institutes of Health said they began to test on humans a drug found effective in laboratory tests in combating a virus suspected of causing acquired immune deficiency syndrome, or AIDS. Dr. Samuel Broder, head of the clinical oncology program at the National Cancer Institute, said that so far
Marilyn Chase, Staff Reporter of The Wall Street Journal
WASHINGTON -- When medical sleuths unmasked the virus they believe is responsible for AIDS, spirits soared and so did rhetoric. A triumph over disease, it was said. Rhetoric can t cure an epidemic. By now, 5,500 Americans have contracted acquired immune deficiency syndrome, and almost 2,500, or 45% of them, are dead.
Marilyn Chase, Staff Reporter of The Wall Street Journal
Some new lawsuits arising from AIDS -- acquired immune deficiency syndrome -- are heading for a collision with state laws that protect blood transfusions from product liability claims. AIDS, an incurable and usually fatal disease, primarily strikes homosexuals, Haitians, drug addicts and recipients of blood. Now some m
Jerry E. Bishop, Staff Reporter of The Wall Street Journal
Humans are repaying a debt to the world s cats. The debt was incurred when a lethal cat disease called feline leukemia helped pinpoint a human leukemia virus as a probable cause of human AIDS, or acquired immune deficiency syndrome. Now, scientists say AIDS research is helping in the struggle against feline leukemia.
Marilyn Chase, Staff Reporter of The Wall Street Journal
Genetic Systems Corp. said it formed a joint venture with an affiliate of France s Pasteur Institute to develop and market diagnostic tests for the virus believed to cause acquired immune deficiency syndrome, or AIDS. The announcement rekindles competition between French and U. S. scientists racing to find both cause a
Carolyn Phillips, Staff Reporter of The Wall Street Journal
The Department of Health and Human Services granted five licenses to companies to develop and distribute a blood test for acquired immune deficiency syndrome, or AIDS. A spokeswoman for the federal agency said the companies will get samples of the human cancer virus, HTLV-111. Scientists at the National Cancer Institut
Michael Waldholz, Staff Reporter of The Wall Street Journal
NEW YORK -- Researchers reported what is said to be the first test on humans of a vaccine produced through genetic engineering. Scientists at Merck & Co. said the vaccine, for use against a type of hepatitis, proved completely safe in a study of 37 healthy adults, all Merck employees who volunteered for the test.
Bob Davis, Staff Reporter of The Wall Street Journal
HOPKINTON, Mass. -- Cambridge BioScience Corp. said it filed patent applications in 17 countries outside the U. S. for methods and products to detect Human T-cell Lymphotropic Virus, or HTLV, which this week was identified as the probable cause of acquired immune deficiency syndrome. Cambridge BioScience said it filed
Marilyn Chase, Staff Reporter of The Wall Street Journal
SOUTH SAN FRANCISCO -- Genentech Inc. said its scientists have produced a synthetic form of rare blood protein used in the treatment of people who suffer uncontrolled bleeding. The protein, called Factor VIII, induces clotting in normal people but is either missing or inactive in people who have hemophilia, a disease t
Marilyn Chase, Staff Reporter of The Wall Street Journal
WASHINGTON -- Government scientists announced they have identified a type of human cancer virus that they believe is the probable cause of AIDS, or acquired immune deficiency syndrome. Although a cure for the mysterious and fatal syndrome is still acknowledged to be years away, Margaret Heckler, secretary of Health and
Marilyn Chase, Staff Reporter of The Wall Street Journal
Speculation is mounting in the medical community that researchers soon will announce discovery of a new variation of a human cancer virus that may cause acquired immune deficiency syndrome, the fatal disease marked by the collapse of the victim s immune system. The virus in question, Human T-cell Leukemia Virus, or HTL
SAN FRANCISCO -- The Irwin Memorial Blood Bank here said it will add a second test to screen out blood from donors who may be at risk of developing AIDS, the usually lethal Acquired Immune Deficiency Syndrome. The new test will cost just $5 per unit of blood but will force the blood bank to discard about 6% of the 10,0
Marilyn Chase, Staff Reporter of The Wall Street Journal
When Sam Kushnick died last October, his family wanted to bury him in a Jewish prayer shawl and in his favorite shoes. But undertakers didn t want to touch his body; the death certificate said that he had died of AIDS -- Acquired Immune Deficiency Syndrome. What is unusual about the Kushnick case isn t that an AIDS vic
Marilyn Chase, Staff Reporter of The Wall Street Journal
SAN FRANCISCO -- Doctors are predicting a doubling of AIDS cases in this city to 1,000 by year-end, increasing strain on the health-care system as well as the toll in human suffering. Nationally, more than 3,600 cases have been reported to date, according to the Centers for Disease Control in Atlanta. The incidence of
NEW YORK -- Collaborative Research Inc. said it acquired exclusive rights under a license from Stanford University to develop a method of diagnostic testing for genetic diseases. The research project will use recently invented DNA probe technology to identify inherited disease characteristics on human chromosomes, Coll
NEW YORK -- Revlon Inc. said it received Food and Drug Administration clearance to sell its new drug, heat-treated Factorate, for bleeding associated with hemophilia A. Factorate concentrates are derived from human plasma and manufactured by a Revlon subsidiary, Armour Pharmaceutical Co., Tarrytown, N. Y. Revlon said i
Sanford L. Jacobs, Staff Reporter of The Wall Street Journal
HOW DO YOU RUN a business that has nothing to sell but spends an average of $650,000 a year? With a lot of anxiety and even more attention to raising capital. Greenwich Pharmaceuticals Inc. has no sales and has had a number of crises in a hand-to-mouth existence. Yet, in the 14 years since it was formed, the company ha
This information is designed to support, not replace, the relationship that exists between you and your doctor.